Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 19 - Insights
This week’s Research Roundup highlights the association of apolipoprotein E ε4 with transactive response DNA-binding protein 43.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 10 - Insights
This week’s Research Roundup highlights hepatocellular carcinoma detection by plasma methylated DNA through a discovery, phase I pilot, and phase II clinical validation.
PathWays Case Studies: Nov. 2018 - Insights
Mayo Clinic laboratory experts share three case studies in this month’s “PathWays” post and are challenging you to test your Clinical Pathology, Molecular Diagnostic, Hematopathology, and Dermatology pathology knowledge. Review the cases,...
Mayo Clinic Start-up Earns World Economic Forum Award - Insights
Mayo Clinic startup company Vineti developed first-of-its-kind software package tracking for cell therapies. Vineti’s groundbreaking product captured a World Economic Forum Technology Pioneer Award in the field of health.
COVID-19's dangerous connection to coagulopathy - Insights
Nahla Heikal, M.D., co-director of Mayo Clinic's Special Coagulation Laboratory, addresses the connection between COVID-19 and coagulopathy.
COVID-19 Laboratory Update: July 7 | Minnesota Partnership - Insights
Minnesota reaches milestone of 20,000 daily test capacity Minnesota Governor Tim Walz has announced the state has completed more than half a million
Browse our menu of immunoglobulin E (IgE) antibody testing, which can be useful in the evaluation of patients suspected of having an allergic disease.
Some Interesting Applications in the Medical Laboratory Science Program - Insights
Elizabeth Atneosen, a student in the Mayo Clinic Medical Laboratory Science program, discusses interesting applications she has learned thus far in the program.
Research Archives - Page 33 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and Pathology Research Roundup: April 9 - Insights
This week's research roundup feature: Intrathecal delivery of autologous culture-expanded adipose tissue-derived mesenchymal stem cells (AD-MSC) could be utilized to treat traumatic spinal cord injury (SCI). This Phase I trial...